The Gross Margin of Tibet Rhodiola Pharmaceutical Holding Co (600211.SS) is 94.22%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 94.22% |
| 2022-12-31 | 91.98% |
| 2021-12-31 | 89.44% |
| 2020-12-31 | 85.75% |
| 2019-12-31 | 83.45% |
| 2018-12-31 | 79.90% |
| 2017-12-31 | 73.74% |
| 2016-12-31 | 76.31% |
| 2015-12-31 | 32.17% |
| 2014-12-31 | 20.29% |